Skip to main content
. 2022 May 5;12:843064. doi: 10.3389/fonc.2022.843064

Figure 5.

Figure 5

RP9P affects colorectal cancer (CRC) cell viability via miR-133a-3p. (A) RP9P and miR-133a-3p levels in shRP9P-, miR-133a-3p inhibitor-, or nonsense control (NC)- transfected CRC cells. (B) Cell proliferation was measured using the CCK-8 assay. (C, D) Apoptosis after cell transfection was analyzed using flow cytometry (C). The histograms show the average numbers of apoptotic cells (D) (***p < 0.001).